← Back to Clinical Trials
Recruiting NCT04950218
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
Trial Parameters
Condition Psoriasis
Sponsor Herlev and Gentofte Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-09-01
Completion 2034-10-01
All Conditions
Psoriasis Cardiovascular Diseases Cardiovascular Risk Factor Cardiovascular Pathology Psoriasis Vulgaris Psoriatic Nail Psoriasis Face Psoriasis Guttate Psoriasis Gyrata Psoriasis Diffusa Psoriasis Palmaris Psoriasis Annularis Psoriasis Circinata Psoriasis Plantaris Psoriasis Universalis Psoriasis Geographica Left Ventricular Dysfunction Myocardial Infarction Myocardial Ischemia Heart Failure Stroke Heart Diseases Heart Failure, Systolic Heart Failure, Diastolic
Brief Summary
In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.
Eligibility Criteria
Inclusion Criteria: * Patients 18 years or older with a diagnosis of psoriasis will be invited to participate Exclusion Criteria: * Patients not able to cooperate to the study * Patients unable understand and sign informed consent
Related Trials
NCT06399432
Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patie
View Trial →
NCT04347473
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
View Trial →
NCT04864886
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
View Trial →